Collegium Pharmaceutical, Inc

Ownership Transactions Reported by 20 Insiders

Symbol
COLL on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Technology Center Drive, Stoughton, MA

Insiders trading volume in the past year

Collegium Pharmaceutical, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rubric Capital Management LP 10%+ Owner $119M -$946K -0.79% Aug 13, 2025
Joseph Ciaffoni President and CEO, Director $15M Feb 12, 2024
Colleen Tupper EVP & Chief Financial Officer $4.7M -$675K -12.5% Mar 20, 2025
Alison B. Fleming EVP & Chief Technical Officer $4.64M Aug 10, 2021
Richard Malamut EVP and Chief Medical Officer $4.2M Feb 10, 2022
Scott Dreyer EVP & Chief Commercial Officer $3.96M -$2.13M -35% Aug 18, 2025
Vikram Karnani President and CEO, Director $3.88M Nov 12, 2024
Gino Santini Director $3.53M -$201K -5.38% Aug 15, 2025
Shirley R. Kuhlmann EVP and General Counsel $3.08M -$3.34M -52% Mar 4, 2025
John G. Freund Director $2.99M -$603K -16.8% Aug 8, 2025
Thomas B. Smith EVP and Chief Medical Officer $2.7M -$672K -19.9% Aug 29, 2025
David Dieter EVP & General Counsel $2.05M Mar 17, 2025
John A. Fallon Director $1.73M May 15, 2025
Gwen A. Melincoff Director $1.69M May 16, 2024
Garen Bohlin Director $1.67M May 15, 2025
Neil F. McFarlane Director $1.59M May 16, 2024
Michael Thomas Heffernan Director $1.54M Feb 10, 2025
Rita J. Balice-Gordon Director $1.51M May 15, 2025
Nancy Lurker Director $603K May 15, 2025
Carlos V. Paya Director $524K May 15, 2025

Recent Insider Transactions by Companies or Individuals for Collegium Pharmaceutical, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.